DoD, Melanoma, Idea Award | HT942524MRPIA

Opportunity Information: Apply for HT942524MRPIA

The FY24 Department of Defense Melanoma Research Program (MRP) Idea Award (Funding Opportunity Number HT942524MRPIA) is a discretionary grant opportunity administered by the U.S. Army Medical Research Acquisition Activity (USAMRAA) to support bold, early-stage melanoma research. It is designed specifically for ideas that are genuinely new and not yet proven, with an emphasis on high-risk concepts that could produce high-reward breakthroughs if they work. Projects must align with at least one of the FY24 MRP Focus Areas referenced in the announcement, meaning applicants need to frame their proposed work around the program priorities rather than general melanoma research.

The central purpose of the Idea Award is to open up new research directions, so novelty is not just encouraged but expected. Proposed studies should introduce a new paradigm, challenge existing assumptions, or approach persistent problems in melanoma from an unconventional angle. The program is looking for creative, exploratory work that is either hypothesis-driven (testing a clear, articulated hypothesis) or hypothesis-generating (producing evidence that helps form a strong future hypothesis). Even though the award targets early concepts, the application still needs to be rigorous: a well-developed study design and a clear analysis plan are required, showing that the idea is innovative but also testable and logically constructed.

This mechanism is particularly welcoming to investigators who are new to the melanoma field, which can make it attractive to researchers coming from adjacent disciplines or different disease areas who can bring fresh tools, theories, or methods. At the same time, the announcement draws a firm line against projects that simply continue an established research trajectory. The Idea Award is not meant to extend previously published findings, expand ongoing work already funded in the PI's lab, or deliver incremental progress that represents the next predictable step. Likewise, simply porting an existing cancer research approach into melanoma, without a truly innovative twist, is explicitly framed as insufficient. The program wants more than a change in disease label; it wants a different way of thinking or a genuinely new approach.

The expected endpoint for funded projects is the creation of strong preliminary data that can serve as a launchpad for future melanoma-focused proposals. Because the award is meant for untested ideas, the inclusion of preliminary data is discouraged. Applications built on substantial preliminary results or already supported by other funding are expected to fit better under other MRP mechanisms where preliminary data is appropriate or required. If any preliminary data are included in an Idea Award application, they should be limited to truly serendipitous observations or unexpected results that arose from unrelated work, reinforcing the exploratory spirit rather than signaling that the project is already well-advanced.

Administratively, this opportunity is a grant in the Science and Technology and other Research and Development activity category (CFDA 12.420). Eligibility is listed as unrestricted, indicating a broad applicant pool. The original closing date was August 26, 2024, and the program anticipated making about 11 awards. The award ceiling is not specified in the provided listing, so applicants would need to consult the full announcement for budget limits, performance period details, and any cost or submission constraints.

• The Dept. of the Army -- USAMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "DoD, Melanoma, Idea Award" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420.
• This funding opportunity was created on 2024-05-08.
• Applicants must submit their applications by 2024-08-26. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 11 candidate(s).
• Eligible applicants include: Unrestricted.

Apply for HT942524MRPIA

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: